1. Home
  2. ALLR vs CHR Comparison

ALLR vs CHR Comparison

Compare ALLR & CHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • CHR
  • Stock Information
  • Founded
  • ALLR 2004
  • CHR 2016
  • Country
  • ALLR United States
  • CHR China
  • Employees
  • ALLR N/A
  • CHR N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • CHR EDP Services
  • Sector
  • ALLR Health Care
  • CHR Technology
  • Exchange
  • ALLR Nasdaq
  • CHR Nasdaq
  • Market Cap
  • ALLR 15.8M
  • CHR 13.3M
  • IPO Year
  • ALLR N/A
  • CHR N/A
  • Fundamental
  • Price
  • ALLR $1.66
  • CHR $0.74
  • Analyst Decision
  • ALLR Strong Buy
  • CHR
  • Analyst Count
  • ALLR 1
  • CHR 0
  • Target Price
  • ALLR $9.00
  • CHR N/A
  • AVG Volume (30 Days)
  • ALLR 21.5M
  • CHR 757.3K
  • Earning Date
  • ALLR 08-15-2025
  • CHR 07-30-2025
  • Dividend Yield
  • ALLR N/A
  • CHR N/A
  • EPS Growth
  • ALLR N/A
  • CHR N/A
  • EPS
  • ALLR N/A
  • CHR 1.76
  • Revenue
  • ALLR N/A
  • CHR $147,134,000.00
  • Revenue This Year
  • ALLR N/A
  • CHR N/A
  • Revenue Next Year
  • ALLR N/A
  • CHR N/A
  • P/E Ratio
  • ALLR N/A
  • CHR $0.41
  • Revenue Growth
  • ALLR N/A
  • CHR N/A
  • 52 Week Low
  • ALLR $0.61
  • CHR $0.65
  • 52 Week High
  • ALLR $3.91
  • CHR $3.45
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 59.12
  • CHR 28.80
  • Support Level
  • ALLR $1.78
  • CHR $0.71
  • Resistance Level
  • ALLR $1.92
  • CHR $1.06
  • Average True Range (ATR)
  • ALLR 0.25
  • CHR 0.11
  • MACD
  • ALLR 0.02
  • CHR -0.02
  • Stochastic Oscillator
  • ALLR 52.25
  • CHR 15.54

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About CHR Cheer Holding Inc.

Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.

Share on Social Networks: